Skip to main content
Premium Trial:

Request an Annual Quote

Enzymatics, UT-Austin Develop Room Temp-Stable NGS Library Construction Kits

Premium

Enzymatics said recently that it has collaborated with scientists from the University of Texas, Austin, to develop a portfolio of room temperature-stable library construction kits for Illumina's sequencing platforms.

In addition, Enzymatics said it is working with UT-Austin to develop similar kits for Life Tech's Ion Torrent sequencing platforms.

The Beverly, Mass.-based company said that the room temperature-stable kits feature lyophilized reagent mixes that are precisely aliquoted and QC tested. Lyophilization enables the kits to be stored at ambient temperatures, eliminating the need for dry ice shipping, freezer storage, and lab bench ice buckets, Enzymatics said.

A spokesperson for the company said that the kits have been validated on the Illumina MiSeq and HiSeq, and that validation on the Ion Torrent PGM and Proton are currently in progress.

Enzymatics said that it has filed patents on the technology and is seeking commercialization partners.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.